Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;4(1):177-97.
doi: 10.1002/cphy.c130024.

Energy metabolism in the liver

Affiliations
Review

Energy metabolism in the liver

Liangyou Rui. Compr Physiol. 2014 Jan.

Abstract

The liver is an essential metabolic organ, and its metabolic function is controlled by insulin and other metabolic hormones. Glucose is converted into pyruvate through glycolysis in the cytoplasm, and pyruvate is subsequently oxidized in the mitochondria to generate ATP through the TCA cycle and oxidative phosphorylation. In the fed state, glycolytic products are used to synthesize fatty acids through de novo lipogenesis. Long-chain fatty acids are incorporated into triacylglycerol, phospholipids, and/or cholesterol esters in hepatocytes. These complex lipids are stored in lipid droplets and membrane structures, or secreted into the circulation as very low-density lipoprotein particles. In the fasted state, the liver secretes glucose through both glycogenolysis and gluconeogenesis. During pronged fasting, hepatic gluconeogenesis is the primary source for endogenous glucose production. Fasting also promotes lipolysis in adipose tissue, resulting in release of nonesterified fatty acids which are converted into ketone bodies in hepatic mitochondria though β-oxidation and ketogenesis. Ketone bodies provide a metabolic fuel for extrahepatic tissues. Liver energy metabolism is tightly regulated by neuronal and hormonal signals. The sympathetic system stimulates, whereas the parasympathetic system suppresses, hepatic gluconeogenesis. Insulin stimulates glycolysis and lipogenesis but suppresses gluconeogenesis, and glucagon counteracts insulin action. Numerous transcription factors and coactivators, including CREB, FOXO1, ChREBP, SREBP, PGC-1α, and CRTC2, control the expression of the enzymes which catalyze key steps of metabolic pathways, thus controlling liver energy metabolism. Aberrant energy metabolism in the liver promotes insulin resistance, diabetes, and nonalcoholic fatty liver diseases.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Glucose metabolism pathways
Gluconeogenic pathways are marked in blue, and the pentose phosphate pathway is marked in orange. GCK: glucokinase; G6Pase: glucose-6-phosphatase; G6P: glucose 1-phosphate; G1P: glucose 1-phosphate; GP: glycogen phosphorylase; GS: glycogen synthase; PFK: 6-phosphofructo-1 kinase; FBPase: fructose 1,6 bisphosphatase; F-1,6-P:; GAP: glyceraldehyde 3-phosphate; DHAP: dihydroxyacetone phosphate; L-PK: liver pyruvate kinase; PC: pyruvate carboxylase; PDC: pyruvate dehydrogenase complex; PDKs: pyruvate dehydrogenase kinases.
Fig. 2
Fig. 2
Regulation of glucose and fatty acid metabolism by insulin (A) and glucagon (B) in the liver.
Fig. 3
Fig. 3. Lipogenic pathways
Lipogenic enzymes are marked in blue. ACL: ATP-citrate lyase; ACC: acetyl-CoA carboxylase; FAS: fatty acid synthase; Elovls: fatty acyl-CoA elongases; SCDs: stearoyl-CoA desaturases; TAG: triacylglycerol.

References

    1. Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G, Wakil SJ. The subcellular localization of acetyl-CoA carboxylase 2. Proc Natl Acad Sci U S A. 2000;97:1444–1449. - PMC - PubMed
    1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 2001;291:2613–2616. - PubMed
    1. Abu-Elheiga L, Matzuk MM, Kordari P, Oh W, Shaikenov T, Gu Z, Wakil SJ. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc Natl Acad Sci U S A. 2005;102:12011–12016. - PMC - PubMed
    1. Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 2008;414:1–18. - PubMed
    1. Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B. Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology. 2006;147:2432–2441. - PubMed

Publication types

MeSH terms